SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026)
SANUWAVE Health (SNWV) posted quarterly Cash from Financing Activities of -$1.4 million for Q1 2026, down 2389.47% year-over-year from $61979.3 in Q1 2025, and down 14.34% quarter-over-quarter from -$1.2 million in Q4 2025.
SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has reported Cash from Financing Activities for 16 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 2389.47% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$6.9 million (down 211.1% YoY), while the FY2025 annual figure was -$5.6 million, down 187.93% from the prior year.
- Cash from Financing Activities retreated to -$1.4 million in Q1 2026 per SNWV's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $7.6 million in Q3 2022 and bottomed at -$4.4 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged $1.3 million across 5 years, with a median of $274000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 1943.29% — and 2026, when it plunged 2389.47%.
- SANUWAVE Health's Cash from Financing Activities stood at $4.7 million in 2022, then plunged by 60.7% to $1.9 million in 2023, then surged by 248.95% to $6.5 million in 2024, then sank by 119.17% to -$1.2 million in 2025, then decreased by 14.34% to -$1.4 million in 2026.
- Business Quant data shows SNWV's Cash from Financing Activities at -$1.4 million in Q1 2026, -$1.2 million in Q4 2025, and -$4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | SANUWAVE Health | 42.32 Mn | 32.94 Mn | 7.42 Mn | -1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.38 Mn |
| Jun 30, 2026 | -1.38 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -4.45 Mn |
| Sep 30, 2025 | -4.45 Mn |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | -57,000.00 |
| Mar 31, 2025 | -57,000.00 |
| Dec 31, 2024 | 6.47 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | -435,000.00 |
| Sep 30, 2024 | -435,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |